NeoGenomics (NEO) Reports In-Line Q4 EPS, Offers Guidance
Get Alerts NEO Hot Sheet
Join SI Premium – FREE
NeoGenomics (NASDAQ: NEO) reported Q4 EPS of $0.06, in-line with the analyst estimate of $0.06. Revenue for the quarter came in at $106.9 million versus the consensus estimate of $104.24 million.
GUIDANCE:
NeoGenomics sees FY2020 revenue of $464-474 million, versus the consensus of $448.3 million.
For earnings history and earnings-related data on NeoGenomics (NEO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- O'Reilly Automotive (ORLY) Misses Q1 EPS by 7c, Offers Guidance
- Alamos Gold (AGI) Misses Q1 EPS by 1c
- ATN International (ATNI) Misses Q1 EPS by 46c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!